These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14680758)

  • 1. Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity.
    Bull EJ; Hutson PH; Fone KC
    Neuropharmacology; 2004 Feb; 46(2):202-10. PubMed ID: 14680758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.
    Bull EJ; Hutson PH; Fone KC
    Neuropharmacology; 2003 Mar; 44(4):439-48. PubMed ID: 12646281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
    Bull EJ; Porkess V; Rigby M; Hutson PH; Fone KC
    J Psychopharmacol; 2006 Mar; 20(2):272-80. PubMed ID: 16510485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated adolescent MDMA ("Ecstasy") exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist.
    Biezonski DK; Courtemanche AB; Hong SB; Piper BJ; Meyer JS
    Brain Res; 2009 Feb; 1252():87-93. PubMed ID: 19059385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity.
    Fone KC; Beckett SR; Topham IA; Swettenham J; Ball M; Maddocks L
    Psychopharmacology (Berl); 2002 Feb; 159(4):437-44. PubMed ID: 11823897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
    Jones K; Brennan KA; Colussi-Mas J; Schenk S
    Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the repeated administration of the compound 3,4-methylenedioxymethamphetamine on the response of rats to the 5-HT2A,C receptor agonist (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
    Granoff MI; Ashby CR
    Neuropsychobiology; 1998; 37(1):36-40. PubMed ID: 9438270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination.
    van Nieuwenhuijzen PS; Long LE; Hunt GE; Arnold JC; McGregor IS
    Psychopharmacology (Berl); 2010 Dec; 212(4):663-74. PubMed ID: 20730418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with a serotonin(2) receptor (5-HT(2)R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA].
    Ross JD; Herin DV; Frankel PS; Thomas ML; Cunningham KA
    Drug Alcohol Depend; 2006 Feb; 81(2):117-27. PubMed ID: 16054778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion.
    Gurtman CG; Morley KC; Li KM; Hunt GE; McGregor IS
    Eur J Pharmacol; 2002 Jun; 446(1-3):89-96. PubMed ID: 12098589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS; Nunes-De-Souza RL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats.
    Thompson MR; Callaghan PD; Hunt GE; McGregor IS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1013-21. PubMed ID: 18302974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.
    McGregor IS; Clemens KJ; Van der Plasse G; Li KM; Hunt GE; Chen F; Lawrence AJ
    Neuropsychopharmacology; 2003 Aug; 28(8):1472-84. PubMed ID: 12700695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists.
    Gudelsky GA; Yamamoto BK; Nash JF
    Eur J Pharmacol; 1994 Nov; 264(3):325-30. PubMed ID: 7698172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.
    Walker QD; Williams CN; Jotwani RP; Waller ST; Francis R; Kuhn CM
    Psychopharmacology (Berl); 2007 Jan; 189(4):435-45. PubMed ID: 17019566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
    Morley KC; Arnold JC; McGregor IS
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT(2A) and D₂ receptors in mice.
    Varela MJ; Brea J; Loza MI; Maldonado R; Robledo P
    Behav Pharmacol; 2011 Aug; 22(4):362-9. PubMed ID: 21712712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute lipopolysaccharide administration on (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2 aminopropane-induced wet dog shake behavior in rats: comparison with body weight change and locomotor activity.
    Kouhata S; Kagaya A; Nakae S; Nakata Y; Yamawaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):395-407. PubMed ID: 11294484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.